NASDAQ:AHCO AdaptHealth (AHCO) Stock Price, News & Analysis → get a piece of the profit from this land (From True Market Insiders) (Ad) Free AHCO Stock Alerts $9.98 +0.13 (+1.32%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$9.67▼$9.9950-Day Range$9.19▼$11.5152-Week Range$6.37▼$15.37Volume540,210 shsAverage Volume1.13 million shsMarket Capitalization$1.33 billionP/E RatioN/ADividend YieldN/APrice Target$12.42 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get AdaptHealth alerts: Email Address AdaptHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside24.4% Upside$12.42 Price TargetShort InterestBearish11.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.74Based on 12 Articles This WeekInsider TradingSelling Shares$2.59 M Sold Last QuarterProj. Earnings Growth38.75%From $0.80 to $1.11 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.25 out of 5 starsMedical Sector321st out of 918 stocksHome Health Care Services Industry5th out of 8 stocks 2.2 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAdaptHealth has only been the subject of 3 research reports in the past 90 days.Read more about AdaptHealth's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.25% of the float of AdaptHealth has been sold short.Short Interest Ratio / Days to CoverAdaptHealth has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in AdaptHealth has recently increased by 9.90%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AHCO. Previous Next 3.2 News and Social Media Coverage News SentimentAdaptHealth has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for AdaptHealth this week, compared to 3 articles on an average week.MarketBeat Follows5 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,586,012.00 in company stock.Percentage Held by Insiders13.60% of the stock of AdaptHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about AdaptHealth's insider trading history. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 38.75% in the coming year, from $0.80 to $1.11 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is -1.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is -1.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAdaptHealth has a PEG Ratio of 0.75. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAdaptHealth has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about AdaptHealth's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceMillionaire Investor makes surprising election predictionMillionaire Investor Makes Surprising Election Prediction Louis Navellier says he knows who's going to win the election. And how they could send six specific AI stocks through the roof on their first day.Click here for the full story… About AdaptHealth Stock (NASDAQ:AHCO)AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Read More AHCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AHCO Stock News HeadlinesMay 17 at 2:44 AM | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Rating Reiterated by Truist FinancialMay 16 at 4:12 PM | markets.businessinsider.comAdaptHealth Growth Concerns Prompt Underperform Rating Amid Operational ChallengesMay 16 at 4:54 AM | americanbankingnews.comAdaptHealth Corp. (NASDAQ:AHCO) Sees Large Growth in Short InterestMay 15 at 6:57 PM | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), Allogene Therapeutics (ALLO)May 15 at 6:57 PM | markets.businessinsider.comBreaking Down AdaptHealth: 4 Analysts Share Their ViewsMay 14, 2024 | msn.comAdaptHealth Executives to Speak at 2024 BofA Securities Health Care ConferenceMay 14, 2024 | investorplace.com3 High-Potential Stocks to Buy at Rock-Bottom PricesMay 14, 2024 | msn.comAdaptHealth Reports Growth Amid Challenges in First Quarter Financial ResultsMay 11, 2024 | finance.yahoo.comAdaptHealth First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | seekingalpha.comAdaptHealth Is Too Strong To Be Valued At 40% Of RevenuesMay 10, 2024 | markets.businessinsider.comAdaptHealth Earns Buy Rating Amid Solid Growth and Strong Financial ProspectsMay 8, 2024 | finance.yahoo.comAdaptHealth Corp. (NASDAQ:AHCO) Q1 2024 Earnings Call TranscriptMay 8, 2024 | businesswire.comAdaptHealth Corp. to Participate in the BofA Securities 2024 Health Care ConferenceMay 8, 2024 | finance.yahoo.comAdaptHealth Corp (AHCO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue and EBITDA ...May 7, 2024 | msn.comAHCO Stock Earnings: AdaptHealth Misses EPS, Beats Revenue for Q1 2024May 7, 2024 | uk.finance.yahoo.comAdaptHealth Corp Reports Mixed Q1 2024 Results: Revenue Up, Net Loss RecordedMay 7, 2024 | businesswire.comAdaptHealth Corp. Announces First Quarter 2024 ResultsMay 6, 2024 | msn.comAdaptHealth Q1 2024 Earnings PreviewApril 23, 2024 | msn.comAdaptHealth Names Suzanne Foster as New CEO, Aiming to Strengthen Its Market PositionApril 22, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)April 18, 2024 | businesswire.comAdaptHealth Corp. Announces First Quarter 2024 Earnings Release Date and Conference CallApril 17, 2024 | fool.comWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth SankApril 17, 2024 | fool.comWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth SankApril 17, 2024 | businesswire.comAdaptHealth Appoints Suzanne Foster as Chief Executive OfficerApril 11, 2024 | businesswire.comRobbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the AdaptHealth Securities LitigationSee More Headlines Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today5/18/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Home health care services Sub-IndustryN/A Current SymbolNASDAQ:AHCO CUSIPN/A CIK1725255 Webwww.adapthealth.com Phone(610) 424-4515FaxN/AEmployees10,700Year FoundedN/APrice Target and Rating Average Stock Price Target$12.42 High Stock Price Target$21.00 Low Stock Price Target$6.50 Potential Upside/Downside+24.4%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($5.27) Trailing P/E RatioN/A Forward P/E Ratio12.48 P/E Growth0.75Net Income$-678,900,000.00 Net Margins-21.45% Pretax Margin-22.58% Return on Equity8.47% Return on Assets3.07% Debt Debt-to-Equity Ratio1.48 Current Ratio1.33 Quick Ratio1.11 Sales & Book Value Annual Sales$3.20 billion Price / Sales0.42 Cash Flow$10.62 per share Price / Cash Flow0.94 Book Value$11.04 per share Price / Book0.90Miscellaneous Outstanding Shares133,200,000Free Float114,832,000Market Cap$1.33 billion OptionableOptionable Beta1.06 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Joshua Parnes (Age 45)President & Director Comp: $1.33MMr. Jason A. Clemens C.F.A. (Age 45)Chief Financial Officer Comp: $1.13MKey CompetitorsAddus HomeCareNASDAQ:ADUSBrightSpring Health ServicesNASDAQ:BTSGAveanna HealthcareNASDAQ:AVAHEnhabitNYSE:EHABAmedisysNASDAQ:AMEDView All CompetitorsInsiders & InstitutionsComerica BankSold 3,356 shares on 5/17/2024Ownership: 0.028%Walleye Trading LLCBought 100 shares on 5/17/2024Ownership: 0.000%Kennedy Capital Management LLCSold 88,710 shares on 5/16/2024Ownership: 1.163%California State Teachers Retirement SystemSold 11,440 shares on 5/16/2024Ownership: 0.058%Bayesian Capital Management LPBought 36,343 shares on 5/16/2024Ownership: 0.027%View All Insider TransactionsView All Institutional Transactions AHCO Stock Analysis - Frequently Asked Questions Should I buy or sell AdaptHealth stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares. View AHCO analyst ratings or view top-rated stocks. What is AdaptHealth's stock price target for 2024? 5 analysts have issued 1 year price targets for AdaptHealth's stock. Their AHCO share price targets range from $6.50 to $21.00. On average, they anticipate the company's share price to reach $12.42 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts. How have AHCO shares performed in 2024? AdaptHealth's stock was trading at $7.29 at the start of the year. Since then, AHCO stock has increased by 36.9% and is now trading at $9.98. View the best growth stocks for 2024 here. When is AdaptHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our AHCO earnings forecast. How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) announced its quarterly earnings data on Tuesday, February, 27th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.44. The firm had revenue of $858.23 million for the quarter, compared to analyst estimates of $825.94 million. AdaptHealth had a positive trailing twelve-month return on equity of 8.47% and a negative net margin of 21.45%. What ETFs hold AdaptHealth's stock? ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap 600 Pure Value ETF (RZV) and Harbor Small Cap Explorer ETF (QWST).Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ). What guidance has AdaptHealth issued on next quarter's earnings? AdaptHealth updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.3 billion. What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS). Who are AdaptHealth's major shareholders? AdaptHealth's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.54%), Reinhart Partners LLC. (3.17%), Kennedy Capital Management LLC (1.16%), Silvercrest Asset Management Group LLC (0.83%), First Eagle Investment Management LLC (0.45%) and Peregrine Capital Management LLC (0.41%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Albert A Prast, Christopher J Joyce, Daniel Bunting, David Solomon Williams III, Everest Hill Group Inc, Frank Mullen, James E Flynn, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs. View institutional ownership trends. How do I buy shares of AdaptHealth? Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AHCO) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
